Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Assessment of MDD Management in Andalusia
A completed AstraZeneca-sponsored clinical trial in Andalusia assessed management strategies for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Comparison of Depression Interventions After Acute Coronary Syndrome [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 results for depression interventions after acute coronary syndrome; completed with results posted …
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Cognitive Bias Modification (CBM) Via Imagery and Internet Cognitive Behavioural Therapy (iCBT) for Depression [NA]
A completed clinical trial evaluated Cognitive Bias Modification via imagery and internet-based Cognitive Behavioral Therapy for depression.…
-
FDA approval · 2014-08-11FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for a fluoxetine hydrochloride generic product submitted by PAI Holdings (PAI Pharma).
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients [Phase 4]
Phase 4 trial update evaluating the effectiveness of repetitive transcranial magnetic stimulation in patients with major depressive disorder…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Safety and Efficacy of Vilazodone in Major Depressive Disorder [Phase 4]
Phase 4 trial evaluating the safety and efficacy of vilazodone for major depressive disorder has been completed, with results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder [Phase 2]
Phase 2 trial results evaluating the safety and efficacy of Levomilnacipran ER for fatigue associated with Major Depressive Disorder in adul…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression [Phase 2]
Phase 2 safety and effectiveness study of JNJ-18038683 in adults with Major Depressive Disorder has been completed. The results assess safet…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression [Phase 3]
This Phase 3 clinical trial update reports the results of using bupropion (Wellbutrin) to treat residual and cognitive symptoms in patients …
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: The Effect of Methylated Vitamin B Complex on Depression [NA]
A completed clinical trial evaluated the effect of methylated vitamin B complex on depression. The sponsor was the University of Miami.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder [Phase 3]
Phase 3 study evaluating vortioxetine for cognitive dysfunction in adults with major depressive disorder; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: A Study of Sertraline to Prevent PTSD [Phase 4]
Phase 4 study evaluating sertraline for prevention of posttraumatic stress disorder after trauma has completed and results were posted in 20…
-
CLINICAL_TRIALS research · 2014-08-01Clinical Trial Update: Homecare Agency-Randomized Trial of Web Implementation Strategy for Depression [NA]
A homecare agency–level randomized trial evaluates a web-based implementation strategy to improve depression care; no results or phase infor…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Integrated Treatment for Comorbid Depression and Obesity in Adolescents [Phase 1]
A Phase 1 clinical trial evaluating an integrated treatment for adolescents with co-occurring depression and obesity has been completed.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Effectiveness of The Step Up Wellness Program for People With Depression [NA]
This update reports the completion and posting of results for a Kaiser Permanente–sponsored clinical trial evaluating the Step Up Wellness P…
-
CLINICAL_TRIALS research · 2014-07-23Clinical Trial Update: Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/Phase 2 study examining mindfulness-based stress reduction for cognitive function in individual…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Comparing Paroxetine and Duloxetine on Cardiovascular Measures [Phase 2, Phase 3]
A Phase 2/3 trial comparing paroxetine and duloxetine on cardiovascular measures in patients with depressive symptoms has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing duloxetine with escitalopram to evaluate effects on heart rate variability in adults with Major Depress…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Randomised Controlled Trial of Method of Levels Cognitive Therapy [NA]
This update reports on a completed randomized controlled trial evaluating Method of Levels Cognitive Therapy for depression and anxiety.
-
FDA approval · 2014-07-18FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., indicating an update to labeling …
-
FDA label_change · 2014-07-18FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories. The update concerns this generic product's regulatory s…
-
FDA approval · 2014-07-18FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2014-07-18FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc. The approval indicates changes to th…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression [Phase 3]
Phase 3 clinical trial assessing the safety and effectiveness of EPA versus DHA omega-3 fatty acids for the treatment of major depressive di…
-
FDA approval · 2014-07-18FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride generic from Lannett Company, Inc.